CN106668267A - 一种三步法治疗犬胃肠炎的药物及其使用方法 - Google Patents

一种三步法治疗犬胃肠炎的药物及其使用方法 Download PDF

Info

Publication number
CN106668267A
CN106668267A CN201611268204.9A CN201611268204A CN106668267A CN 106668267 A CN106668267 A CN 106668267A CN 201611268204 A CN201611268204 A CN 201611268204A CN 106668267 A CN106668267 A CN 106668267A
Authority
CN
China
Prior art keywords
parts
medicine
weight
gastroenteritis
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611268204.9A
Other languages
English (en)
Inventor
董子强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201611268204.9A priority Critical patent/CN106668267A/zh
Publication of CN106668267A publication Critical patent/CN106668267A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268Asarum (wild ginger)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533Leonurus (motherwort)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/66Papaveraceae (Poppy family), e.g. bloodroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734Crataegus (hawthorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明属于犬类疾病治疗技术领域,具体涉及本发明属于犬类疾病治疗技术领域,具体涉及一种三步法治疗犬胃肠炎的药物及其使用方法,包括静脉注射、肌肉注射和中药灌肠三步。本发明相比现有技术具有以下优点:按照本发明中三步法治疗犬胃肠炎,疗效快,普通病症进行一次,病症严重则需要重复两次,治疗完成后能够有效止吐,排泄规律,粪便恢复正常,有效改善食欲不振的症状,能够降低肠道损伤,有效保护肠道,平衡肠道内生态平衡,治疗后观察一周无反复,治愈率达到94%左右,适于推广使用。

Description

一种三步法治疗犬胃肠炎的药物及其使用方法
技术领域
本发明属于犬类疾病治疗技术领域,具体涉及一种三步法治疗犬胃肠炎的药物及其使用方法。
背景技术
犬胃肠炎是犬较常见的一种消化道疾病,由于家犬经长期驯养后,已不适合吃不卫生和不易消化的食物,否则会很容易导致胃肠炎,通常包括传染性出血性肠炎、食物性肠炎和异物性肠炎等类型,现有的防治方法通过加强对狗的管理,治疗主要以补液和口服液为主,治疗周期通常持续3-4天,治疗后肠胃受到一定损伤,食欲需要很长时间恢复,因此需要一种疗效快,能使患病犬快速恢复食欲的治疗方法。
发明内容
本发明的目的是针对现有的问题,提供了一种三步法治疗犬胃肠炎的药物及其使用方法。
本发明是通过以下技术方案实现的:一种三步法治疗犬胃肠炎的药物,包括以下内容:
(1)静脉注射液包括:质量浓度为5%的糖盐水500-1000ml、庆大霉素20-30万单位、VB60.5-0.8g、VC 0.2-0.6g、地塞米松0.1-0.2g、止血芳酸0.2-0.4g、细辛挥发油0.1-0.2g;
(2)肌肉注射液包括:按重量份计,注射用水80-100份、VB1 4-6份、吗啉胍2-3份、爱茂尔2-8份、茺蔚子提纯物1-2份;其中茺蔚子提纯物的制备方法为,将茺蔚子加10倍的水煎煮3次,每次熬煮40-80分钟,合并三次煎煮液,离心取上清液,水煎液上D-4020大孔树脂柱,每克树脂上0.4-0.8ml药液,大孔树脂用3-5倍重的纯净水洗脱,弃去水洗液,再用6-8倍的60%的乙醇洗脱,回收洗脱液中的乙醇,减压抽干,收集残留物溶于相当于其重量6倍的质量浓度为98%的乙醇中,过滤,回收乙醇并抽干,再用相当于其重量4倍的质量浓度为98%的乙醇溶解、再抽干,最后溶于质量浓度为98%的乙醇中,在超声波频率为22-24kHz的情况下处理30秒,放置,析出结晶、过滤,得到茺蔚子提纯物;
(3)中药灌肠液的制备方法,按重量份计,取黄柏30份、莲须20份、白头翁20份、仙鹤草20份、炒地榆45份、焦楂45份、米壳6份、苦参20份、香橼15份混合后水煎三次,合并滤液,得到中药灌肠液。
作为对上述方案的进一步改进,所述中药灌肠液的制备方法为:按重量份计,取黄柏30份、莲须20份、白头翁20份、仙鹤草20份、炒地榆45份、焦楂45份、米壳6份、苦参20份、白芨15份、炒大黄20份、藕节炭8份、磺胺结晶粉12份、枯矾6份、云南白药6份混合后水煎三次,合并滤液,即得。
作为对上述方案的进一步改进,所述细辛挥发油由细辛药材加入相当于其重量10倍的水中,浸泡6小时后,用水蒸气蒸馏法提取挥发油4小时得到。
作为对上述方案的进一步改进,所述步骤3中药物在相当于其重量4-5份的水中煎煮三次,每次的煎煮时间依次为3小时、2.5小时和2小时。
一种三步法治疗犬胃肠炎药物的使用方法,所述中药灌肠液在使用时平均分成两次灌肠,两次灌肠中间间隔时间为1.5-2小时。
本发明相比现有技术具有以下优点:按照本发明中三步法治疗犬胃肠炎,疗效快,普通病症进行一次,病症严重则需要重复两次,治疗完成后能够有效止吐,排泄规律,粪便恢复正常,有效改善食欲不振的症状,能够降低肠道损伤,有效保护肠道,平衡肠道内生态平衡,治疗后观察一周无反复,治愈率达到94%左右,适于推广使用。
具体实施方式
实施例1
一种三步法治疗犬胃肠炎的药物,包括以下内容:
(1)静脉注射液包括:质量浓度为5%的糖盐水500-1000ml、庆大霉素20万单位、VB60.5g、VC 0.4g、地塞米松0.1g、止血芳酸0.4g、细辛挥发油0.2g;
(2)肌肉注射液包括:按重量份计,注射用水100g、VB1 4g、吗啉胍3g、爱茂尔6g、茺蔚子提纯物1g;其中茺蔚子提纯物的制备方法为,将茺蔚子加10倍的水煎煮3次,每次熬煮40-80分钟,合并三次煎煮液,离心取上清液,水煎液上D-4020大孔树脂柱,每克树脂上0.4-0.8ml药液,大孔树脂用3-5倍重的纯净水洗脱,弃去水洗液,再用6-8倍的60%的乙醇洗脱,回收洗脱液中的乙醇,减压抽干,收集残留物溶于相当于其重量6倍的质量浓度为98%的乙醇中,过滤,回收乙醇并抽干,再用相当于其重量4倍的质量浓度为98%的乙醇溶解、再抽干,最后溶于质量浓度为98%的乙醇中,在超声波频率为22-24kHz的情况下处理30秒,放置,析出结晶、过滤,得到茺蔚子提纯物;
(3)中药灌肠,按重量份计,取黄柏30g、莲须20g、白头翁20g、炒地榆45g、焦楂45g、米壳6g、苦参20g、香橼15g混合后,用相当于其重量4-5倍的水煎煮三次,每次的煎煮时间依次为3小时、2.5小时和2小时,合并滤液,得到中药灌肠液。
其中,所述细辛挥发油由细辛药材加入相当于其重量10倍的水中,浸泡6小时后,用水蒸气蒸馏法提取挥发油4小时得到。
其中,所述中药灌肠液在使用时平均分成两次灌肠,两次灌肠中间间隔时间为1.5-2小时。
对50例患有胃肠炎的犬,进行治疗,静脉注射液的注射量为60-100ml,注射速度为20滴/ml,肌肉注射液的注射量为5-10ml,按常规方法深部灌肠,进行一次三步法治疗后,治愈42例,7例有效,1例无效,对有效例第二次三步法治疗后,治愈7例,有效例在治愈后观察1周,无反复,说明该发明中治疗方法见效快,治愈率高。
实施例2
一种三步法治疗犬胃肠炎的药物,包括以下内容:
(1)静脉注射液包括:质量浓度为5%的糖盐水800ml、庆大霉素30万单位、VB6 0.8g、VC0.4g、地塞米松0.2g、止血芳酸0.3g、细辛挥发油0.2g;
(2)肌肉注射液包括:注射用水100g、VB1 4g、吗啉胍3g、爱茂尔5g、茺蔚子提纯物2g;
(3)所述中药灌肠液的制备方法为:按重量份计,取黄柏30g、莲须20g、白头翁20g、炒地榆45g、焦楂45g、米壳6g、苦参20g、白芨15g、炒大黄20g、藕节炭8g、磺胺结晶粉12g、枯矾6g、云南白药6g混合后水煎三次,合并滤液,即得,中药灌肠液分两次深部灌肠。
其余内容与实施例1相同。
病例1,一只体重为9.8kg,2周杂交狗就诊,该狗发病4-6天,体温38.5℃,病情严重,精神较差,消瘦、喜卧底、鼻盘偏干,每天呕吐6-8次,排稀水粪便,一天5-6次,犬细小病毒病检测为阴性,按照实施例2中方法治疗,按三步法治疗1次后,呕吐症状明显缓解,精神有所恢复,第二次治疗后完全康复,观察7天无复发。
病例2,一只体重为5.8kg、3周的纯种北京狗就诊,该狗发病2-3天,每天呕吐2-3次,排稀水粪便,一天7-8次,,体温为39.2℃,鼻盘偏干,脱水,精神差,犬细小病毒病检测为阴性,按照实施例1中方法治疗,按三步法治疗1次后,完全康复,呕吐症状和排稀症状消失,食欲基本恢复,观察7天,无反复。

Claims (5)

1.一种三步法治疗犬胃肠炎的药物,其特征在于,包括静脉注射液,肌肉注射液和中药灌肠液,具体内容如下:
(1)静脉注射液包括:质量浓度为5%的糖盐水500-1000ml、庆大霉素20-30万单位、VB60.5-0.8g、VC 0.2-0.6g、地塞米松0.1-0.2g、止血芳酸0.2-0.4g、细辛挥发油0.1-0.2g;
(2)肌肉注射液包括:按重量份计,注射用水80-100份、VB1 4-6份、吗啉胍2-3份、爱茂尔2-8份、茺蔚子提纯物1-2份;其中茺蔚子提纯物的制备方法为,将茺蔚子加10倍的水煎煮3次,每次熬煮40-80分钟,合并三次煎煮液,离心取上清液,水煎液上D-4020大孔树脂柱,每克树脂上0.4-0.8ml药液,大孔树脂用3-5倍重的纯净水洗脱,弃去水洗液,再用6-8倍的60%的乙醇洗脱,回收洗脱液中的乙醇,减压抽干,收集残留物溶于相当于其重量6倍的质量浓度为98%的乙醇中,过滤,回收乙醇并抽干,再用相当于其重量4倍的质量浓度为98%的乙醇溶解、再抽干,最后溶于质量浓度为98%的乙醇中,在超声波频率为22-24kHz的情况下处理30秒,放置,析出结晶、过滤,得到茺蔚子提纯物;
(3)中药灌肠液的制备方法,按重量份计,取黄柏30份、莲须20份、白头翁20份、仙鹤草20份、炒地榆45份、焦楂45份、米壳6份、苦参20份、香橼15份混合后水煎三次,合并滤液,得到中药灌肠液。
2.一种如权利要求1所述三步法治疗犬胃肠炎的药物,其特征在于,所述中药灌肠液的制备方法为:按重量份计,取黄柏30份、莲须20份、白头翁20份、仙鹤草20份、炒地榆45份、焦楂45份、米壳6份、苦参20份、白芨15份、炒大黄20份、藕节炭8份、磺胺结晶粉12份、枯矾6份、云南白药6份混合后水煎三次,合并滤液,即得。
3.如权利要求1或2所述一种三步法治疗犬胃肠炎的药物,其特征在于,所述细辛挥发油由细辛药材加入相当于其重量10倍的水中,浸泡6小时后,用水蒸气蒸馏法提取挥发油4小时得到。
4.如权利要求1或2所述一种三步法治疗犬胃肠炎的药物,其特征在于,所述步骤3中药物在相当于其重量4-5份的水中煎煮三次,每次的煎煮时间依次为3小时、2.5小时和2小时。
5.一种如权利要求1或2所述三步法治疗犬胃肠炎药物的使用方法,其特征在于,所述中药灌肠液在使用时平均分成两次灌肠,两次灌肠中间间隔时间为1.5-2小时。
CN201611268204.9A 2016-12-31 2016-12-31 一种三步法治疗犬胃肠炎的药物及其使用方法 Pending CN106668267A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611268204.9A CN106668267A (zh) 2016-12-31 2016-12-31 一种三步法治疗犬胃肠炎的药物及其使用方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611268204.9A CN106668267A (zh) 2016-12-31 2016-12-31 一种三步法治疗犬胃肠炎的药物及其使用方法

Publications (1)

Publication Number Publication Date
CN106668267A true CN106668267A (zh) 2017-05-17

Family

ID=58850177

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611268204.9A Pending CN106668267A (zh) 2016-12-31 2016-12-31 一种三步法治疗犬胃肠炎的药物及其使用方法

Country Status (1)

Country Link
CN (1) CN106668267A (zh)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109935A (zh) * 2016-07-26 2016-11-16 谢晓玲 一种治疗犬胃肠炎的中药

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109935A (zh) * 2016-07-26 2016-11-16 谢晓玲 一种治疗犬胃肠炎的中药

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
常影: "茺蔚子化学成分及药理研究", 《吉林中医药》 *
朱印生等: "《宠物疾病防治彩色图册》", 30 June 2003, 江西科学技术出版社 *

Similar Documents

Publication Publication Date Title
CN1524542A (zh) 一种治疗急慢性鼻炎及副鼻窦炎药物
CN107951980B (zh) 玉簪花及其提取物在制备治疗慢性前列腺炎的药物中的用途
CN108329368A (zh) 一种从黄芩中制备黄芩苷的方法
CN101112446B (zh) 猪蓝耳病的治疗配方、制作方法及其药液使用方法
US10653746B2 (en) Medicament for use in treating gout
CN1056775C (zh) 一种治疗泌尿系结石的药物
CN111973651A (zh) 甘草在治疗与肠道菌群紊乱相关疾病中的用途
CN106668267A (zh) 一种三步法治疗犬胃肠炎的药物及其使用方法
CN104173546A (zh) 治疗鼻炎的中药水
CN104383486A (zh) 一种治疗小儿支气管炎药物
CN104367888A (zh) 一种治疗急慢龟头炎药物
CN101683396A (zh) 一种金莲花总黄酮的提取方法
CN101224235B (zh) 治疗猪附红细胞体病药物及其制备方法和用途
CN1020855C (zh) 排除泌尿系结石的中药冲剂的制备方法
CN108743667A (zh) 一种治疗鼻炎的中药组合物、其制备方法及药物制剂
CN100417410C (zh) 治疗胃肠型暑湿感冒的药物及其制备方法
CN102406673A (zh) 预防治疗呼吸道、泌尿系统感染的土牛膝酮苷药物及其制剂、制备方法
CN105497641A (zh) 一种治疗慢性咽喉炎的中药
CN107468976B (zh) 一种钻山风合剂
CN108261459A (zh) 治疗宠物结石的中药组合物及其制备方法
CN106362079B (zh) 一种健胃中药产品及其制备方法
CN101579410B (zh) 一种治疗前列腺肥大的药物组合物
CN101972333B (zh) 泄浊通瘀剂
CN109276608A (zh) 一种治疗胃痛的汤药
CN101380449A (zh) 一种治疗畜禽消化道疾病的中药组合物及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170517

RJ01 Rejection of invention patent application after publication